Method for producing N-acetyllactosamine and composition containing N-acetyllactosamine
The enzymatic reaction with lactose and β-galactosidase from Bacillus or Bifidobacterium, optimizing the lactose-to-N-acetylglucosamine ratio, addresses the cost and flavor issues of existing methods, enabling efficient and cost-effective production of N-acetyllactosamine for food applications.
Patent Information
- Application Number
- JP2024557380
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-11-11
- Filing Date
- 2023-11-06
- Publication Date
- 2026-11-19
- Estimated Expiration
- 2043-11-06
AI Technical Summary
Existing methods for producing N-acetyllactosamine for food use are costly due to the use of expensive substrates and enzymes, and require complex concentration processes that affect flavor, making them unsuitable for industrial application.
A method involving an enzymatic reaction using lactose as the Gal donor and β-galactosidase derived from Bacillus or Bifidobacterium, with a lactose-to-N-acetylglucosamine molar ratio of 1.1:1, achieving a conversion rate of 20% or more, thus eliminating the need for costly concentration steps and maintaining flavor integrity.
This method enables efficient production of N-acetyllactosamine with a high molar ratio, allowing its use in food products at a lower cost without flavor deterioration.
Smart Images

Figure 0007954216000001
Abstract
Description
TECHNICAL FIELD
[0001] The present invention relates to a method for producing N-acetyllactosamine and an N-acetyllactosamine-containing composition. BACKGROUND ART
[0002] N-acetyllactosamine (hereinafter sometimes simply referred to as LacNAc) is an oligosaccharide composed of a disaccharide in which galactose (hereinafter sometimes simply referred to as Gal) is linked to N-acetylglucosamine (hereinafter sometimes simply referred to as GlcNAc) via a β-1,4 bond. LacNAc is a biochemically very important oligosaccharide that is present in human milk oligosaccharides, lipopolysaccharides, and the sugar chains of various glycoproteins and glycolipids. It is also known as a growth factor for bifidobacteria, which are one type of intestinal bacteria, and is a substance useful as a functional food material. As methods for producing LacNAc, a chemical synthesis method and a synthesis method using a Gal transferase with uridine diphosphate galactose (UDP-Gal) and GlcNAc as substrates are known. However, the chemical synthesis method requires the use of harmful reagents and solvents that cannot be used in food applications. In addition, in the synthesis method using Gal glycosyltransferase, UDP-Gal and Gal transferase as substrates are extremely expensive. Therefore, industrial production of LacNAc intended for food use is not possible with these synthesis methods. On the other hand, as a simple synthesis method for LacNAc, a method utilizing the transglycosylation activity of β-galactosidase is known. This synthesis method is a method of transferring the Gal residue of lactose (also called milk sugar) or p-nitrophenyl-Galactoside (PNP-Gal) to GlcNAc. Patent documents 1, 2, and 3 disclose methods for preparing LacNAc using β-galactosidase derived from Diprococcus pneumoniae, Bifidobacterium, and Bacillus, respectively. These methods use PNP-Gal as a Gal donor. However, since PNP-Gal is a synthetic substrate that cannot be used in food, the LacNAc prepared by these methods cannot be applied to food. Furthermore, methods for preparing compositions containing a large amount of LacNAc require a step of concentrating the LacNAc after preparing it using β-galactosidase. However, this preparation method is undesirable as a method for preparing food compositions because it increases manufacturing costs. Therefore, a method is preferred in which LacNAc can be used directly in food without going through a concentration step after preparation. To add LacNAc directly to food without concentration after preparation, lactose, an inexpensive and safe sugar, is desirable as the Gal donor. GlcNAc, the Gal receptor, is produced from crustaceans such as shrimp and crabs, and certain plants, and high-purity GlcNAc suitable for food use is commercially available. However, commercially available GlcNAc for food use is significantly more expensive than lactose. Therefore, if conditions can be found to convert GlcNAc to LacNAc more efficiently, it will be possible to produce LacNAc at a low cost. In other words, in order to use LacNAc in food at a low cost without going through a complicated concentration process, it is necessary to (1) use inexpensive and safe lactose as the Gal donor, and (2) find conditions for an enzymatic reaction that has a high conversion rate from GlcNAc to LacNAc, which is used as a Gal receptor. Patent Document 4 discloses a method for preparing LacNAc by reacting a solution containing lactose and GlcNAc with β-galactosidase derived from Bacillus circulans. Patent Document 4 also discloses the preparation of LacNAc by setting the molar ratio of lactose to GlcNAc (lactose / GlcNAc ratio) to 0.25-0.5. Furthermore, Patent Document 4 states that the conversion rate from GlcNAc to LacNAc is at most about 15%, and that the molar ratio of N-acetyllactosamine (LacNAc) to N-acetylglucosamine (GlcNAc) (LacNAc / GlcNAc) is at most 0.18 (Example (1)). Patent Document 5 discloses a method for producing LacNAc by reacting lactose and GlcNAc with β-galactosidase. This method discloses a method for preparing LacNAc in high yield by using β-galactosidase and glucose oxidase as enzymes. It also states that the conversion rate from GlcNAc to LacNAc reached a maximum of 21% with this method (Table 1). However, it is preferable not to add enzyme preparations such as glucose oxidase because it leads to increased costs and deterioration of the flavor of the composition. [Prior art documents] [Patent Documents]
[0003] [Patent Document 1] Japanese Patent Application Publication No. 6-335395 [Patent Document 2] Japanese Patent Application Publication No. 10-23898 [Patent Document 3] Patent No. 6771756 [Patent Document 4] Patent No. 2819312 [Patent Document 5] Japanese Patent Publication No. 2001-292791 [Overview of the Initiative] [Problems that the invention aims to solve]
[0004] The object of the present invention is to provide a method for producing an N-acetyllactosamine-containing composition using lactose, N-acetylglucosamine, and β-galactosidase, wherein the conversion rate from N-acetylglucosamine to N-acetyllactosamine is higher than that of conventional methods. The present invention is also to provide an N-acetyllactosamine composition by such a method in which the molar ratio of N-acetyllactosamine to N-acetylglucosamine (LacNAc / GlcNAc) is 0.26 or higher. [Means for solving the problem]
[0005] As a result of diligent research to solve the above problems, we discovered that the above problems can be solved by setting the concentration of lactose before the enzymatic reaction to 1.1 times or more the concentration of N-acetylglucosamine in terms of molar mass, and thus completed the present invention. That is, the present invention has the following configuration. <1> A method for producing N-acetyllactosamine, comprising the step of contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase, characterized in that the concentration of lactose in the solution before contact with β-galactosidase is 1.1 times or more in molar ratio relative to the concentration of N-acetylglucosamine. <2> Only β-galactosidase is used as the enzyme. <1> The manufacturing method described above. <3> The conversion rate from N-acetylglucosamine to N-acetyllactosamine via enzymatic reaction is 20% or more in terms of molar mass. <1> or <2> The manufacturing method described above. <4> The β-galactosidase is derived from a bacterium of the genus Bacillus or Bifidobacterium. <1> or <2> The manufacturing method described above. <5> A method for producing N-acetyllactosamine, comprising the step of contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase, wherein the β-galactosidase is β-galactosidase derived from a bacterium of the genus Bifidobacterium. <6> Only β-galactosidase is used as the enzyme. <5> The manufacturing method described above. <7> The conversion rate from N-acetylglucosamine to N-acetyllactosamine via enzymatic reaction is 20% or more in terms of molar mass. <5> or <6> The manufacturing method described above. <8> <1> , <2> , <5> , <6> An N-acetyllactosamine-containing composition manufactured by any of the methods described herein, characterized in that the molar ratio (LacNAc / GlcNAc) of N-acetyllactosamine (LacNAc) contained in the composition is 0.26 or higher. <9> An N-acetyllactosamine-containing composition produced by contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase as the enzyme, characterized in that the molar ratio (LacNAc / GlcNAc) of N-acetyllactosamine (LacNAc) to N-acetylglucosamine (GlcNAc) is 0.26 or higher. [Effects of the Invention]
[0006] According to the present invention, by setting the concentration of lactose before the enzymatic reaction to 1.1 times or more the concentration of N-acetylglucosamine in terms of molar mass, it is possible to provide a method for producing N-acetyllactosamine with a high conversion rate from N-acetylglucosamine to N-acetyllactosamine. This production method can efficiently convert N-acetylglucosamine to N-acetyllactosamine even by using only β-galactosidase as the enzyme. Therefore, this production method is inexpensive and does not negatively affect the flavor. Furthermore, since the conversion efficiency from N-acetylglucosamine to N-acetyllactosamine is high in this manufacturing method, it is possible to provide an N-acetyllactosamine-containing composition suitable for food use at low cost without having to go through a complicated concentration process after the enzymatic reaction. [Modes for carrying out the invention]
[0007] (Manufacturing method) The present invention relates to a method for producing N-acetyllactosamine by an enzymatic reaction involving the action of β-galactosidase on lactose and N-acetylglucosamine, comprising the step of contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase, wherein the concentration of lactose in the solution before the action of β-galactosidase is 1.1 times or more in molar proportion to the concentration of N-acetylglucosamine. Typically, this method involves adding β-galactosidase, an enzyme having galactose transfer activity, to a solution containing lactose and N-acetylglucosamine as substrates, and allowing the enzyme to act on the substrates to produce N-acetyllactosamine. In this production method, by making the concentration of lactose in the solution before the action of β-galactosidase 1.1 times or more in molar proportion to the concentration of N-acetylglucosamine, N-acetyllactosamine can be produced efficiently. As for the enzyme, other enzymes can be added as long as they do not inhibit the galactose transfer activity of β-galactosidase. For example, by adding glucose oxidase, it is possible to remove glucose, which is a reaction byproduct of the N-acetyllactosamine enzyme synthesis reaction using lactose and N-acetylglucosamine as substrates. However, for the sake of flavor and cost reduction, it is desirable to use only β-galactosidase as the enzyme. According to the production method of the present invention, even by using only β-galactosidase as the enzyme, it is possible to achieve a conversion rate of 20% or more from N-acetylglucosamine to N-acetyllactosamine.
[0008] (β-galactosidase) In the production method of the present invention, β-galactosidase refers to an enzyme that catalyzes the reaction of transferring a galactose residue from lactose to N-acetylglucosamine, and is not particularly limited to any enzyme that exhibits such activity. As such an enzyme, in addition to purified enzymes, stationary bacterial cells, dried bacterial cells, and bacterial cell lysates that exhibit the activity of the enzyme can also be used. Specific examples of enzymes include purified or partially purified β-galactosidase derived from bacteria of the following genera: Bacillus (e.g., Bacillus circulans), Rhodotorula (e.g., Rhodotorula minuta and Rhodotorula lactosa), Streptococcus (e.g., Streptococcus pneumoniae and Streptococcus sp.6646k), Sterigmatomyces (e.g., Sterigmatomyces circulans), and Bifidobacterium. Substances containing the enzyme (e.g., stationary bacterial cells, dried bacterial cells, or bacterial cell lysates) can also be preferably used. N-acetyllactosamine is a disaccharide in which D-galactose and N-acetylglucosamine are linked by a β-1,4-glycosidic bond. Therefore, β-galactosidase with high specificity for the β-1,4-glycosidic bond is preferred. In particular, purified or partially purified β-galactosidase enzyme derived from Bacillus or Bifidobacterium species, or a substance containing said enzyme (such as stationary bacterial cells, dried bacterial cells, or bacterial cell fragments) is more preferred.
[0009] The concentration of β-galactosidase can be appropriately set by those skilled in the art so that the above enzymatic reaction proceeds favorably. When β-galactosidase is used, the final concentration is preferably 0.1 U / ml to 100 U / ml, and more preferably 0.1 U / ml to 10 U / ml. Here, the enzymatic activity of 1 U of β-galactosidase is defined as the amount of enzyme that releases 1 μmol of glucose per minute when the enzyme is added to a lactose solution (pH 6.5) and reacted at 50°C for 10 minutes.
[0010] The enzymatic reaction in the production method of the present invention is a reaction in which β-galactosidase is reacted with lactose and N-acetylglucosamine in a solution (e.g., aqueous solution, buffer solution) containing these substrates to produce N-acetyllactosamine. The reaction conditions are not limited as long as the enzymatic reaction proceeds. The enzymatic reaction is preferably carried out in a buffer solution at the optimal pH and temperature for β-galactosidase. For example, when using β-galactosidase from the genus Bacillus, it is preferable to carry out the enzymatic reaction in a buffer solution that can maintain the pH at pH 4 to 9 and 5 to 70°C. When using β-galactosidase from the genus Bifidobacterium, it is preferable to carry out the enzymatic reaction in a buffer solution that can maintain the pH at pH 4 to 9 and 5 to 70°C.
[0011] Lactose and N-acetylglucosamine, which are substrates for the above enzymatic reaction, are usually used as aqueous solutions or buffer solutions containing lactose and N-acetylglucosamine. The content and ratio of each substance are not particularly limited as long as they do not interfere with the above enzymatic reaction. Lactose is preferably used at a concentration of about 0.5 to 1.5 M, more preferably about 1 M. N-acetylglucosamine is preferably used at a concentration of about 0.05 to 1 M, more preferably about 0.5 M. The concentration of lactose in the solution before the start of the enzymatic reaction should be at least 1.1 times the concentration of N-acetylglucosamine in molar ratio, preferably about 1.1 to 52 times, and even more preferably about 1.1 to 5 times. This molar ratio can be determined by dividing the concentration of lactose (M) of the substrate before the start of the enzymatic reaction by the concentration of N-acetylglucosamine (M) of the substrate before the start of the enzymatic reaction. If the aforementioned molar ratio is 1.1 times or more, the conversion rate from N-acetylglucosamine to N-acetyllactosamine will be 20% or more, regardless of the type of β-galactosidase. Furthermore, the higher the mass ratio of lactose / N-acetylglucosamine, the higher the conversion rate from N-acetylglucosamine to N-acetyllactosamine. On the other hand, the higher the mass ratio of lactose / N-acetylglucosamine, the lower the actual mass of the N-acetyllactosamine produced. That is, when the mass ratio of lactose / N-acetylglucosamine is low, the production amount of N-acetyllactosamine increases, but the conversion rate from N-acetylglucosamine to N-acetyllactosamine decreases, resulting in waste of expensive N-acetylglucosamine. Therefore, in order to achieve a conversion rate of 20% or more from N-acetylglucosamine to N-acetyllactosamine and a mass of N-acetyllactosamine above a certain level, it is desirable to adjust the concentration of lactose before the start of the enzymatic reaction to be 1.1 times or more in terms of substance amount relative to the concentration of N-acetylglucosamine before the enzymatic reaction.
[0012] The conversion rate from N-acetylglucosamine to N-acetyllactosamine after the enzymatic reaction is desirably as high as possible, preferably 20% or more in terms of substance amount, more preferably 21% or more, and even more preferably 25% or more. The conversion rate can be determined by multiplying the value obtained by dividing the N-acetyllactosamine concentration (M) after the completion of the enzymatic reaction by the N-acetylglucosamine concentration (M) of the substrate before the start of the enzymatic reaction by 100.
[0013] (N-acetyllactosamine-containing composition) The N-acetyllactosamine-containing composition of the present invention is a composition in which the molar ratio (LacNAc / GlcNAc) of N-acetyllactosamine to N-acetylglucosamine is 0.26 or higher. The composition can be produced by a method comprising the step of allowing only β-galactosidase as an enzyme to act on a solution containing lactose and N-acetylglucosamine. In particular, the composition can be produced by allowing β-galactosidase to act on a solution in which the concentration of lactose in the solution containing lactose and N-acetylglucosamine is 1.1 times or more in terms of molar ratio relative to the concentration of N-acetylglucosamine. When only β-galactosidase as an enzyme is allowed to act on lactose and N-acetylglucosamine, no other extra products are generated, so the advantage of less impact on flavor can be expected. The above molar ratio (LacNAc / GlcNAc) is a value obtained by dividing the LacNAc concentration (M) after the completion of the enzymatic reaction by the GlcNAc concentration (M). Here, the GlcNAc concentration (M) after the completion of the enzymatic reaction can also be substituted with a value obtained by subtracting the LacNAc concentration (M) after the completion of the enzymatic reaction from the GlcNAc concentration (M) of the substrate before the start of the enzymatic reaction.
Examples
[0014] [Example 1] 1. Test Method To 1 mL of 50 mM acetate buffer (pH 6.0) in which lactose and N-acetylglucosamine (GlcNAc) were dissolved under 9 levels of conditions shown in Table 1, β-galactosidase derived from a bacterium of the genus Bifidobacterium (Novozymes Japan Ltd.: Saphera Fiber) or β-galactosidase derived from a bacterium of the genus Bacillus (Amano Enzyme Inc.: Biolacta FN5) was added to prepare N-acetyllactosamine (LacNAc). The reaction was stopped by boiling the reaction solution for 5 minutes. Subsequently, lactose and N-acetyllactosamine (LacNAc) in the solution after the completion of the enzymatic reaction were respectively quantified by ion chromatography under the following detection conditions. The conversion rate to N-acetyllactosamine (LacNAc) was calculated using the following formula (1). The LacNAc / GlcNAc molar ratio was calculated using the following formula (2). The results are shown in Table 1.
[0015] (Formula 1) Conversion rate to LacNAc (%) = LacNAc concentration in solution after enzyme reaction (M) ÷ GlcNAc concentration of substrate (M) × 100
[0016] (Formula 2) LacNAc / GlcNAc molar ratio = LacNAc concentration in solution after enzymatic reaction (M) ÷ (GlcNAc concentration of substrate (M) - LacNAc concentration in solution after enzymatic reaction (M))
[0017] <Ion chromatography detection conditions> Column: CarboPac PA1 (manufactured by Thermo Fisher Scientific) Mobile phase: 100mM NaOH Flow rate: 1 mL / min Temperature: 25℃ Detector: Electrochemical detector Sample: 10 uL
[0018] [Table 1]
[0019] 2. Results and Discussion Table 1 shows that the higher the lactose / GlcNAc molar ratio, the higher the conversion rate from N-acetylglucosamine to N-acetyllactosamine. If the lactose concentration before the enzymatic reaction was 1.1 times or more the N-acetylglucosamine concentration in terms of molar mass, the conversion rate from N-acetylglucosamine to N-acetyllactosamine reached 20% or more, regardless of the type of enzyme. The higher the proportion of N-acetylglucosamine (the lower the lactose / GlcNAc molar ratio), the greater the amount of N-acetyllactosamine produced. However, a higher proportion of N-acetylglucosamine leads to a decrease in the conversion rate from N-acetylglucosamine to N-acetyllactosamine, resulting in wasted expensive N-acetylglucosamine. Therefore, it was found that in order to convert expensive N-acetylglucosamine into N-acetyllactosamine at a rate of 20% or more, the concentration of lactose before the enzymatic reaction should be adjusted so that it is 1.1 times or more in terms of molar mass relative to the concentration of N-acetylglucosamine. Furthermore, the (LacNAc / GlcNAc) molar ratio of N-acetyllactosamine to N-acetylglucosamine in the N-acetyllactosamine-containing composition prepared by this manufacturing method was 0.26 or higher.
[0020] [Example 2] 1. Test Method A solution was prepared by adding 17.6% skim milk powder (8.4% lactose concentration) and 4.3% N-acetylglucosamine material (Yaizu Suisan Kagaku Kogyo Co., Ltd.: Marine Sweet YM40) at an N-acetylglucosamine concentration. To this solution, β-galactosidase derived from Bacillus bacteria (Amano Enzyme Co., Ltd.: Biolacta FN5) was added at a concentration of 5.0 U / mL and the reaction was carried out at 7°C for 20 hours. After that, the reaction solution was boiled for 5 minutes to stop the reaction. Subsequently, the amount of LacNAc produced was measured by ion chromatography under the conditions of Example 1.
[0021] 2.Results The amount of N-acetyllactosamine produced was 1.6% (conversion rate from GlcNAc was 21%), and the molar ratio of N-acetyllactosamine to N-acetylglucosamine (LacNAc / GlcNAc) in the obtained N-acetyllactosamine-containing composition was 0.52. In addition, the molar ratio of lactose / GlcNAc of the substrate in this example was 1.3.
[0022] [Example 3] 1. Test Method A 100 kg aqueous solution was prepared by dissolving 32 kg of desalted whey powder (25 kg as lactose) and 6.3 kg of N-acetylglucosamine material (Yaizu Suisan Kagaku Kogyo Co., Ltd.: Marine Sweet YM40) as N-acetylglucosamine. 500,000 U of β-galactosidase derived from Bifidobacterium (Novozymes Japan Co., Ltd.: Saphera Fiber) was added to this aqueous solution and the reaction was carried out at 50°C for 1 hour. The reaction was then stopped by heating the reaction solution at 95°C for 10 minutes. Subsequently, the amount of LacNAc produced was measured by ion chromatography, as in Example 1.
[0023] 2.Results The amount of N-acetyllactosamine produced was 3.0 kg (conversion rate from GlcNA was 27%). The molar ratio of N-acetyllactosamine to N-acetylglucosamine (LacNAc / GlcNAc) in the obtained N-acetyllactosamine-containing composition was 0.38. The lactose / GlcNAc ratio of the substrate in this example was 2.6. [Industrial applicability]
[0024] The present invention provides a method for producing N-acetyllactosamine with a high conversion rate from N-acetylglucosamine to N-acetyllactosamine. Using the production method of the present invention, inexpensive and safe lactose can be used as a Gal donor, and expensive N-acetylglucosamine, used as a Gal receptor, can be efficiently converted to N-acetyllactosamine. Therefore, N-acetyllactosamine usable in food can be produced at a lower cost than conventional methods, without the need for a complicated concentration process.
Claims
1. A method for producing an N-acetyllactosamine-containing composition, comprising the step of contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase, characterized in that the concentration of lactose in the solution before contact with β-galactosidase is 1.1 times or more in molar ratio relative to the concentration of N-acetylglucosamine, The β-galactosidase is derived from a bacterium of the genus Bacillus or Bifidobacterium. The manufacturing method, wherein the molar ratio (LacNAc / GlcNAc) of N-acetyllactosamine (LacNAc) to N-acetylglucosamine (GlcNAc) contained in the N-acetyllactosamine-containing composition is 0.26 or higher.
2. The manufacturing method according to claim 1, wherein only β-galactosidase is used as the enzyme.
3. The manufacturing method according to claim 1 or 2, wherein the conversion rate from N-acetylglucosamine to N-acetyllactosamine by enzymatic reaction is 20% or more in terms of molar mass.
4. A method for producing an N-acetyllactosamine-containing composition, comprising the step of contacting a solution containing lactose and N-acetylglucosamine with β-galactosidase, wherein the β-galactosidase is β-galactosidase derived from a bacterium of the genus Bifidobacterium, The manufacturing method, wherein the molar ratio (LacNAc / GlcNAc) of N-acetyllactosamine (LacNAc) to N-acetylglucosamine (GlcNAc) contained in the N-acetyllactosamine-containing composition is 0.26 or higher.
5. The manufacturing method according to claim 4, wherein only β-galactosidase is used as the enzyme.
6. The manufacturing method according to claim 4 or 5, wherein the conversion rate from N-acetylglucosamine to N-acetyllactosamine by enzymatic reaction is 20% or more in terms of molar mass.
Citation Information
Patent Citations
Production of lacto-n-biose i and 2-acetamide-2-deoxy-3-o-beta-d-galactopyranosyl-d-galactopyranose
JP1994253878A
Production of n-acetyl-lactosamine
JP1994335395A
New production of n-acetyllactosamine derivative
JP1998023898A
Method for producing n-acetyllactosmine
JP2001292791A
Chitin oligosaccharide derivative, n-acetyllactosamine derivative and process for producing both
JP2011116699A
